Publications 75 Datasets 392.5k Experiments 4.7k

Explore

75 matching publication(s)

Publication	Journal	Year	Score	Verdict
Specific signature biomarkers highlight the potential mechanisms of circulating neutrophils in aneurysmal subarachnoid hemorrhage. PMID 36438795	Front Pharmacol	2022	80	L1 80/100
Identification of intrinsic genes across general hypertension, hypertension with left ventricular remodeling, and uncontrolled hypertension. PMID 36277786	Front Cardiovasc Med	2022	73	L1 73/100
Artificial Intelligence Meets Whole Slide Images: Deep Learning Model Shapes an Immune-Hot Tumor and Guides Precision Therapy in Bladder Cancer. PMID 36245985	J Oncol	2022	—	not yet assessed
AI-assisted discovery of an ethnicity-influenced driver of cell transformation in esophageal and gastroesophageal junction adenocarcinomas. PMID 36134663	JCI Insight	2022	84	L1 84/100
T Cells With Activated STAT4 Drive the High-Risk Rejection State to Renal Allograft Failure After Kidney Transplantation. PMID 35844542	Front Immunol	2022	78	L1 78/100
Identifying Molecular Subtypes and 6-Gene Prognostic Signature Based on Hypoxia for Optimizing Targeted Therapies in Non-Small Cell Lung Cancer. PMID 35509605	Int J Gen Med	2022	59	L1 59/100
Bacillus Calmette-Guérin Treatment Changes the Tumor Microenvironment of Non-Muscle-Invasive Bladder Cancer. ⚑ PMID 35311085	Front Oncol	2022	30	L1 30/100 ⚑
Severe COVID-19 Shares a Common Neutrophil Activation Signature with Other Acute Inflammatory States. PMID 35269470	Cells	2022	88	L2 88/100
The indirect effect of mRNA-based COVID-19 vaccination on healthcare workers' unvaccinated household members. PMID 35246536	Nat Commun	2022	—	L1 No data access
The butyrophilin 1a1 knockout mouse revisited: Ablation of Btn1a1 leads to concurrent cell death and renewal in the mammary epithelium during lactation. PMID 34938960	FASEB Bioadv	2021	98	L1 98/100
Predicting Bone Metastasis Using Gene Expression-Based Machine Learning Models. PMID 34858485	Front Genet	2021	62	L1 62/100
Pathway signatures derived from on-treatment tumor specimens predict response to anti-PD1 blockade in metastatic melanoma. PMID 34654806	Nat Commun	2021	100	L1 100/100
Gene Set Enrichment Analysis Reveals Individual Variability in Host Responses in Tuberculosis Patients. PMID 34421903	Front Immunol	2021	71	71/100
Construction and Validation of an Immune Infiltration-Related Gene Signature for the Prediction of Prognosis and Therapeutic Response in Breast Cancer. ⚑ PMID 33986754	Front Immunol	2021	51	L1 51/100 ⚑
Circulating mucosal-associated invariant T cells identify patients responding to anti-PD-1 therapy. PMID 33723257	Nat Commun	2021	70	L1 70/100
Epigenome screening highlights that JMJD6 confers an epigenetic vulnerability and mediates sunitinib sensitivity in renal cell carcinoma. PMID 33634984	Clin Transl Med	2021	85	L1 85/100
Indoleamine 2, 3-Dioxygenase 1 and CD8 Expression Profiling Revealed an Immunological Subtype of Colon Cancer With a Poor Prognosis. ⚑ PMID 33425745	Front Oncol	2020	48	L1 48/100 ⚑
Prediction of prognostic signatures in triple-negative breast cancer based on the differential expression analysis via NanoString nCounter immune panel. PMID 33138797	BMC Cancer	2020	72	L1 72/100
Evaluating Distribution and Prognostic Value of New Tumor-Infiltrating Lymphocytes in HCC Based on a scRNA-Seq Study With CIBERSORTx. PMID 33043022	Front Med (Lausanne)	2020	78	L1 78/100
Synergism between IL7R and CXCR4 drives BCR-ABL induced transformation in Philadelphia chromosome-positive acute lymphoblastic leukemia. PMID 32581241	Nat Commun	2020	92	L1 92/100
Molecular and Clinical Relevance of ZBTB38 Expression Levels in Prostate Cancer. ⚑ PMID 32365491	Cancers (Basel)	2020	35	L1 35/100 ⚑
Improved precision of epigenetic clock estimates across tissues and its implication for biological ageing. PMID 31443728	Genome Med	2019	68	L1 68/100
A genome-wide association analysis identifies 16 novel susceptibility loci for carpal tunnel syndrome. PMID 30833571	Nat Commun	2019	90	L1 90/100
DNA demethylation is associated with malignant progression of lower-grade gliomas. PMID 30760837	Sci Rep	2019	—	L1 No data access
Distinct lncRNA transcriptional fingerprints characterize progressive stages of multiple myeloma. ⚑ PMID 26895470	Oncotarget	2016	36	L1 36/100 ⚑